Cargando…

Obesity and risk for its comorbidities diabetes, hypertension, and dyslipidemia in Japanese individuals aged 65 years

Diabetes, hypertension, and dyslipidemia are obesity-related comorbidities that contribute to the development of cardiovascular disease, one of the leading causes of death. In addition to obesity, the underweight condition is a concern because it can give rise to sarcopenia, particularly after the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Tomoko, Kimura-Koyanagi, Maki, Sakaguchi, Kazuhiko, Ogawa, Wataru, Tamori, Yoshikazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911391/ https://www.ncbi.nlm.nih.gov/pubmed/36759688 http://dx.doi.org/10.1038/s41598-023-29276-7

Ejemplares similares

Preoperative Serum Cortisol Level Is Predictive of Weight Loss After Laparoscopic Sleeve Gastrectomy in Men with Severe Obesity but Not Women
por: Bando, Hironori, et al.
Publicado: (2023)

Relation of cardiac function to insulin resistance as evaluated by hyperinsulinemic‐euglycemic clamp analysis in individuals with type 2 diabetes
por: Otowa‐Suematsu, Natsu, et al.
Publicado: (2021)

Sex difference in the association of obesity with personal or social background among urban residents in Japan
por: Asahara, Shun-ichiro, et al.
Publicado: (2020)

Sleeve Gastrectomy Induced Remission of Slowly Progressive Type 1 Diabetes in a Morbidly Obese Japanese Patient
por: Hironaka, Jun-ya, et al.
Publicado: (2018)

Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study
por: Otowa-Suematsu, Natsu, et al.
Publicado: (2018)

Association between Prescription and Control Status of Dyslipidemia and Hypertension among Japanese Patients with Diabetes
por: Sakamoto, Miki, et al.
Publicado: (2019)

Effects of ipragliflozin on glycemic control, appetite and its related hormones: A prospective, multicenter, open‐label study (SOAR‐KOBE Study)
por: Miura, Hiroshi, et al.
Publicado: (2019)

DI(/cle), a Measure Consisting of Insulin Sensitivity, Secretion, and Clearance, Captures Diabetic States
por: Sugimoto, Hikaru, et al.
Publicado: (2023)

Effects of Insulin Degludec and Insulin Glargine U300 on Day-to-Day Fasting Plasma Glucose Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study (Kobe Best Basal Insulin Study 2)
por: Miura, Hiroshi, et al.
Publicado: (2018)

Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older
por: McDonald, Margaret, et al.
Publicado: (2009)

Nutrients Intake in Individuals with Hypertension, Dyslipidemia, and Diabetes: An Italian Survey
por: Guastadisegni, Cecilia, et al.
Publicado: (2020)

Carotid intima-media thickness, hypertension, and dyslipidemia in obese adolescents
por: Widjaja, Nur Aisiyah, et al.
Publicado: (2019)

Pancreatic fat content assessed by (1)H magnetic resonance spectroscopy is correlated with insulin resistance, but not with insulin secretion, in Japanese individuals with normal glucose tolerance
por: Komada, Hisako, et al.
Publicado: (2017)

Recent Advances in Obesity-Induced Inflammation and Insulin Resistance
por: Tateya, Sanshiro, et al.
Publicado: (2013)

The Association of Peptide Hormones with Glycemia, Dyslipidemia, and Obesity in Lebanese Individuals
por: Abou-Samra, Murielle, et al.
Publicado: (2022)

Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors
por: Ogawa, Wataru, et al.
Publicado: (2015)

The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang
por: Yao, Xiao-Guang, et al.
Publicado: (2010)

Association of healthy lifestyles on the risk of hypertension, type 2 diabetes mellitus, and their comorbidity among subjects with dyslipidemia
por: Hu, Peng, et al.
Publicado: (2022)

Obesity and Dyslipidemia in South Asians
por: Misra, Anoop, et al.
Publicado: (2013)

Dyslipidemia and Obesity in Ischemic Stroke
por: Gajurel, Bikram P, et al.
Publicado: (2023)

Heterogeneous Comorbidity in Individuals With Different Phenotypes of Obesity
por: Nurieva, Albina R, et al.
Publicado: (2023)

The association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (Central Asian nation) population
por: Мirrakhimov, Erkin М, et al.
Publicado: (2014)

A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia
por: Makhoul, Elias, et al.
Publicado: (2022)

LIPITENSION: Interplay between dyslipidemia and hypertension
por: Dalal, Jamshed J., et al.
Publicado: (2012)

Hypertension and Dyslipidemia Combined Therapeutic Approaches
por: Borghi, Claudio, et al.
Publicado: (2022)

Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects
por: Kuwabara, Masanari, et al.
Publicado: (2018)

Impact of the 8-week Administration of Tofogliflozin for Glycemic Control and Body Composition in Japanese Patients with Type 2 Diabetes Mellitus
por: Hirose, Sachie, et al.
Publicado: (2016)

Fat‐specific protein 27α inhibits autophagy‐dependent lipid droplet breakdown in white adipocytes
por: Nakajima, Shinsuke, et al.
Publicado: (2019)

Frequency of secondary dyslipidemia in obese children
por: Korsten-Reck, Ulrike, et al.
Publicado: (2008)

Dyslipidemia in Iranian overweight and obese children
por: Ghergerehchi, Robabeh
Publicado: (2009)

Dyslipidemia in Obesity: Mechanisms and Potential Targets
por: Klop, Boudewijn, et al.
Publicado: (2013)

The association of dyslipidemia and obesity with glycated hemoglobin
por: Sheth, Jayesh, et al.
Publicado: (2015)

Dyslipidemia, Obesity, and Ethnicity in Mexican Children
por: Costa-Urrutia, Paula, et al.
Publicado: (2021)

Identification of Genetic Variants in 65 Obesity Related Genes in a Cohort of Portuguese Obese Individuals
por: Ginete, Catarina, et al.
Publicado: (2021)

Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database
por: Tanaka, Keiko, et al.
Publicado: (2021)

Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival
por: Schneider, Matthias, et al.
Publicado: (2020)

The Association between Obesity Phenotypes and Early Renal Function Decline in Adults without Hypertension, Dyslipidemia, and Diabetes
por: Choi, Jung In, et al.
Publicado: (2019)

Early administration of dapagliflozin preserves pancreatic β‐cell mass through a legacy effect in a mouse model of type 2 diabetes
por: Kanno, Ayumi, et al.
Publicado: (2018)

Obesity, Dyslipidemia, Diabetes, and Vitamin D Levels
por: Moya, Elena A Amoroso, et al.
Publicado: (2021)

Predictive Power of a Body Shape Index for Development of Diabetes, Hypertension, and Dyslipidemia in Japanese Adults: A Retrospective Cohort Study
por: Fujita, Misuzu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_24183sibaemm23qi1hke470rfr